231 related articles for article (PubMed ID: 24090655)
1. Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma.
Ochs K; Sahm F; Opitz CA; Lanz TV; Oezen I; Couraud PO; von Deimling A; Wick W; Platten M
J Neuroimmunol; 2013 Dec; 265(1-2):106-16. PubMed ID: 24090655
[TBL] [Abstract][Full Text] [Related]
2. Identification of two distinct mesenchymal stromal cell populations in human malignant glioma.
Svensson A; Ramos-Moreno T; Eberstål S; Scheding S; Bengzon J
J Neurooncol; 2017 Jan; 131(2):245-254. PubMed ID: 27757723
[TBL] [Abstract][Full Text] [Related]
3. TGF-β activates pericytes via induction of the epithelial-to-mesenchymal transition protein SLUG in glioblastoma.
Wirsik NM; Ehlers J; Mäder L; Ilina EI; Blank AE; Grote A; Feuerhake F; Baumgarten P; Devraj K; Harter PN; Mittelbronn M; Naumann U
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):768-780. PubMed ID: 33780024
[TBL] [Abstract][Full Text] [Related]
4. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas.
Plate KH; Breier G; Farrell CL; Risau W
Lab Invest; 1992 Oct; 67(4):529-34. PubMed ID: 1434531
[TBL] [Abstract][Full Text] [Related]
6. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment.
Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P
Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646
[TBL] [Abstract][Full Text] [Related]
7. Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis.
Ho IA; Toh HC; Ng WH; Teo YL; Guo CM; Hui KM; Lam PY
Stem Cells; 2013 Jan; 31(1):146-55. PubMed ID: 23034897
[TBL] [Abstract][Full Text] [Related]
8. Endogenous brain pericytes are widely activated and contribute to mouse glioma microvasculature.
Svensson A; Özen I; Genové G; Paul G; Bengzon J
PLoS One; 2015; 10(4):e0123553. PubMed ID: 25875288
[TBL] [Abstract][Full Text] [Related]
9. Interferon-γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity.
Zhang Z; Han Y; Song J; Luo R; Jin X; Mu D; Su S; Ji X; Ren YF; Liu H
J Oral Pathol Med; 2015 Jan; 44(1):15-27. PubMed ID: 25212102
[TBL] [Abstract][Full Text] [Related]
10. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase.
Meisel R; Brockers S; Heseler K; Degistirici O; Bülle H; Woite C; Stuhlsatz S; Schwippert W; Jäger M; Sorg R; Henschler R; Seissler J; Dilloo D; Däubener W
Leukemia; 2011 Apr; 25(4):648-54. PubMed ID: 21242993
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells.
Ryan JM; Barry F; Murphy JM; Mahon BP
Clin Exp Immunol; 2007 Aug; 149(2):353-63. PubMed ID: 17521318
[TBL] [Abstract][Full Text] [Related]
12. Blood vessels expressing CD90 in human and rat brain tumors.
Inoue A; Tanaka J; Takahashi H; Kohno S; Ohue S; Umakoshi A; Gotoh K; Ohnishi T
Neuropathology; 2016 Apr; 36(2):168-80. PubMed ID: 26350700
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory properties of mesenchymal stem cells: cytokines and factors.
Soleymaninejadian E; Pramanik K; Samadian E
Am J Reprod Immunol; 2012 Jan; 67(1):1-8. PubMed ID: 21951555
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of Gliomas.
Segura-Collar B; Garranzo-Asensio M; Herranz B; Hernández-SanMiguel E; Cejalvo T; Casas BS; Matheu A; Pérez-Núñez Á; Sepúlveda-Sánchez JM; Hernández-Laín A; Palma V; Gargini R; Sánchez-Gómez P
Cancer Res; 2021 Apr; 81(8):2142-2156. PubMed ID: 33593822
[TBL] [Abstract][Full Text] [Related]
15. The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro.
Jiao H; Yang B; Guan F; Li J; Shan H; Song L; Hu X; Liang S; Du Y; Jiang C
Neurol Res; 2011 May; 33(4):405-14. PubMed ID: 21535940
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells in infantile hemangioma reside in the perivascular region.
Yuan SM; Chen RL; Shen WM; Chen HN; Zhou XJ
Pediatr Dev Pathol; 2012; 15(1):5-12. PubMed ID: 21689017
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression.
Yang HM; Sung JH; Choi YS; Lee HJ; Roh CR; Kim J; Shin M; Song S; Kwon CH; Joh JW; Kim SJ
Cytotherapy; 2012 Jan; 14(1):70-9. PubMed ID: 21954834
[TBL] [Abstract][Full Text] [Related]
18. Autologous mesenchymal stem cells prevent transplant arteriosclerosis by enhancing local expression of interleukin-10, interferon-γ, and indoleamine 2,3-dioxygenase.
Jui HY; Lin CH; Hsu WT; Liu YR; Hsu RB; Chiang BL; Tseng WY; Chen MF; Wu KK; Lee CM
Cell Transplant; 2012; 21(5):971-84. PubMed ID: 22449499
[TBL] [Abstract][Full Text] [Related]
19. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas.
Bexell D; Gunnarsson S; Tormin A; Darabi A; Gisselsson D; Roybon L; Scheding S; Bengzon J
Mol Ther; 2009 Jan; 17(1):183-90. PubMed ID: 18985030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
